BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10606389)

  • 1. Two cases of nabumetone induced pseudoporphyria.
    Checketts SR; Morgan GJ
    J Rheumatol; 1999 Dec; 26(12):2703-5. PubMed ID: 10606389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory-induced pseudoporphyria: is there an alternative drug?
    Checketts SR; Morrison KA; Baughman RD
    Cutis; 1999 Apr; 63(4):223-5. PubMed ID: 10228751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoporphyria associated with Relafen therapy.
    Magro CM; Crowson AN
    J Cutan Pathol; 1999 Jan; 26(1):42-7. PubMed ID: 10189244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoporphyria induced by nabumetone.
    Krischer J; Scolari F; Kondo-Oestreicher M; Vollenweider-Roten S; Saurat JH; Pechère M
    J Am Acad Dermatol; 1999 Mar; 40(3):492-3. PubMed ID: 10071328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal antiinflammatory drug-induced pseudoporphyria: a case series.
    LaDuca JR; Bouman PH; Gaspari AA
    J Cutan Med Surg; 2002; 6(4):320-6. PubMed ID: 12118363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis.
    Mehta S; Lang B
    Arthritis Rheum; 1999 Oct; 42(10):2252-4. PubMed ID: 10524703
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs.
    Meggitt SJ; Farr PM
    Br J Dermatol; 1999 Sep; 141(3):591-2. PubMed ID: 10583088
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medicine-caused itch, wounds and bullous skin in three patients with pseudoporphyria].
    Þorsteinsdóttir S; Velander MJ; Bygum A
    Ugeskr Laeger; 2015 Apr; 177(17):. PubMed ID: 25922166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabumetone-associated pseudoporphyria.
    Antony F; Layton AM
    Br J Dermatol; 2000 May; 142(5):1067-9. PubMed ID: 10809892
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudoporphyria caused by nabumetone.
    Varma S; Lanigan SW
    Br J Dermatol; 1998 Mar; 138(3):549-50. PubMed ID: 9580823
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the transient intermediates generated from the photoexcitation of nabumetone: a comparison with naproxen.
    Martínez LJ; Scaiano JC
    Photochem Photobiol; 1998 Nov; 68(5):646-51. PubMed ID: 9825693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nabumetone induced pseudoporphyria in childhood.
    Cron RQ; Finkel TH
    J Rheumatol; 2000 Jul; 27(7):1817-8. PubMed ID: 10914877
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudoporphyria induced by propionic acid derivatives.
    Al-Khenaizan S; Schechter JF; Sasseville D
    J Cutan Med Surg; 1999 Jan; 3(3):162-6. PubMed ID: 10082597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diclofenac-induced pseudoporphyria; an under-recognized condition?
    Turnbull N; Callan M; Staughton RC
    Clin Exp Dermatol; 2014 Apr; 39(3):348-50. PubMed ID: 24635077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoporphyria from nonsteroidal antiinflammatory drugs.
    Taylor BJ; Duffill MB
    N Z Med J; 1987 May; 100(824):322-3. PubMed ID: 3451093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed drug eruption due to nabumetone in a patient with previous fixed drug eruptions due to naproxen.
    Pérez-Calderón R; Gonzalo-Garijo MA; Pérez-Rangel I; Sánchez-Vega S; Zambonino MA
    J Investig Allergol Clin Immunol; 2011; 21(2):153-4. PubMed ID: 21462807
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V
    Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe immediate reaction to nabumetone.
    Gonzalo-Garijo MA; Cordobés-Duran C; Lamilla-Yerga AM; Moreno-Gastón I
    J Investig Allergol Clin Immunol; 2007; 17(4):274-6. PubMed ID: 17694703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of oral anticoagulation and hemarthrosis associated with nabumetone.
    Dennis VC; Thomas BK; Hanlon JE
    Pharmacotherapy; 2000 Feb; 20(2):234-9. PubMed ID: 10678303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical review of pseudoporphyria].
    Velander MJ; Þorsteinsdóttir S; Bygum A
    Ugeskr Laeger; 2015 Feb; 177(6):. PubMed ID: 25650579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.